Your browser doesn't support javascript.
loading
Robust test and trace strategies can prevent COVID-19 resurgences: a case study from New South Wales, Australia
Robyn M Stuart; Romesh G Abeysuriya; Cliff C Kerr; Dina Mistry; Daniel J Klein; Richard Gray; Margaret Hellard; Nick Scott.
Affiliation
  • Robyn M Stuart; Department of Mathematical Sciences, University of Copenhagen, Copenhagen, Denmark
  • Romesh G Abeysuriya; Disease Elimination Program, Burnet Institute, Melbourne, Victoria, Australia
  • Cliff C Kerr; Institute for Disease Modeling, Global Health Division, Bill & Melinda Gates Foundation, Seattle, USA
  • Dina Mistry; Institute for Disease Modeling, Global Health Division, Bill & Melinda Gates Foundation, Seattle, USA
  • Daniel J Klein; Institute for Disease Modeling, Global Health Division, Bill & Melinda Gates Foundation, Seattle, USA
  • Richard Gray; The Kirby Institute, UNSW Sydney, Sydney, New South Wales, Australia
  • Margaret Hellard; Disease Elimination Program, Burnet Institute, Melbourne, Victoria, Australia
  • Nick Scott; Disease Elimination Program, Burnet Institute, Melbourne, Victoria, Australia
Preprint in English | medRxiv | ID: ppmedrxiv-20209429
ABSTRACT
ObjectivesThe early stages of the COVID-19 pandemic illustrated that SARS-CoV-2, the virus that causes the disease, has the potential to spread exponentially. Therefore, as long as a substantial proportion of the population remains susceptible to infection, the potential for new epidemic waves persists even in settings with low numbers of active COVID-19 infections, unless sufficient countermeasures are in place. We aim to quantify vulnerability to resurgences in COVID-19 transmission under variations in the levels of testing, tracing, and mask usage. SettingThe Australian state of New South Wales, a setting with prolonged low transmission, high mobility, non-universal mask usage, and a well-functioning test-and-trace system. ParticipantsNone (simulation study) ResultsWe find that the relative impact of masks is greatest when testing and tracing rates are lower (and vice versa). Scenarios with very high testing rates (90% of people with symptoms, plus 90% of people with a known history of contact with a confirmed case) were estimated to lead to a robustly controlled epidemic, with a median of [~]180 infections in total over October 1 - December 31 under high mask uptake scenarios, or 260-1,200 without masks, depending on the efficacy of community contact tracing. However, across comparable levels of mask uptake and contact tracing, the number of infections over this period were projected to be 2-3 times higher if the testing rate was 80% instead of 90%, 8-12 times higher if the testing rate was 65%, or 30-50 times higher with a 50% testing rate. In reality, NSW diagnosed 254 locally-acquired cases over this period, an outcome that had a low probability in the model (4-7%) under the best-case scenarios of extremely high testing (90%), near-perfect community contact tracing (75-100%), and high mask usage (50-75%), but a far higher probability if any of these were at lower levels. ConclusionsOur work suggests that testing, tracing and masks can all be effective means of controlling transmission. A multifaceted strategy that combines all three, alongside continued hygiene and distancing protocols, is likely to be the most robust means of controlling transmission of SARS-CoV-2. Strengths and limitations of this studyO_LIA key methodological strength of this study is the level of detail in the model that we use, which allows us to capture many of the finer details of the extent to which controlling COVID-19 transmission relies on the balance between testing, contact tracing, and mask usage. C_LIO_LIAnother key strength is that our model is stochastic, so we are able to quantify the probability of different epidemiological outcomes under different policy settings. C_LIO_LIA key limitation is the shortage of publicly-available data on the efficacy of contact tracing programs, including data on how many people were contacted for each confirmed index case of COVID-19. C_LI
License
cc_by_nc_nd
Full text: Available Collection: Preprints Database: medRxiv Type of study: Case report / Experimental_studies / Prognostic study Language: English Year: 2020 Document type: Preprint
Full text: Available Collection: Preprints Database: medRxiv Type of study: Case report / Experimental_studies / Prognostic study Language: English Year: 2020 Document type: Preprint
...